Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study

Abstract

This current national wide cohort study suggests that PPI use was associated with an increased risk of fatty liver disease compared with non-use of PPIs. Clinicians should consider fatty liver as a potential risk when prescribing PPI.